SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-22-000064
Filing Date
2022-03-03
Accepted
2022-03-03 16:07:04
Documents
14
Period of Report
2022-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20220303.htm   iXBRL 8-K 34442
2 EX-99.1 q421eolsex991.htm EX-99.1 200439
6 evoluslogohorizontala02.jpg GRAPHIC 368311
  Complete submission text file 0001570562-22-000064.txt   888572

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20220303.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20220303_lab.xml EX-101.LAB 24927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20220303_pre.xml EX-101.PRE 13147
8 EXTRACTED XBRL INSTANCE DOCUMENT eols-20220303_htm.xml XML 11071
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 22708683
SIC: 2834 Pharmaceutical Preparations